Ibrance 100 MG tablet 7S
Ended Awarded
- Contract number
- SPE2DR26F9AH4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,120
Award facts
- Contract value 100% obligated
- $17,119.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,119.68 delivery order to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg tablets (7-count units) under a firm fixed-price contract. The award was issued on November 5, 2025, with an ultimate completion date of November 28, 2025. This non-set-aside award represents a competitive procurement through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement valued through December 2026. Performance of this delivery order will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal healthcare vendor, particularly for military and veteran medical systems. As the prime contractor under the DLA's Pharmaceutical Prime Vendor program, the company fulfills a wide spectrum of pharmaceutical requirements including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Ibrance, an oncology medication, exemplifies AmerisourceBergen's role in supporting military healthcare programs through the flexible and comprehensive DLA supply chain vehicle.
Quick answers
Who was awarded contract SPE2DR26F9AH4?
SPE2DR26F9AH4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26F9AH4 worth?
The government has obligated $17,120 on SPE2DR26F9AH4.
Is contract SPE2DR26F9AH4 an order under another contract?
Yes. SPE2DR26F9AH4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9AH4 competed?
The extent of competition for SPE2DR26F9AH4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award